|
Spondylarthropathies
Citations 141-150 of 281 total displayed.
|
Past content
(since Apr 2000):
|
- CLINICAL
Safety of anti-TNF- therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis
- C. H. Roux, O. Brocq, V. Breuil, C. Albert, and L. Euller-Ziegler
Rheumatology 2006; 45: 1294-1297.
[Abstract]
[Full Text]
- CASE REPORTS
Effective co-administration of infliximab and etanercept following the failure of sequential anti-TNF agents in a patient with HLA-B27-associated arthropathy
- C. Sheehy, E. Murphy, and M. Barry
Rheumatology 2006; 45: 1314-1315.
[Extract]
[Full Text]
- CASE REPORTS
Successful treatment of juvenile-onset HLA-B27-associated severe and refractory heel Thesitis with adalimumab documented by magnetic resonance imaging
- I. Olivieri, E. Scarano, P. Gigliotti, V. Giasi, and A. Padula
Rheumatology 2006; 45: 1315-1317.
[Extract]
[Full Text]
- MATTERS ARISING
Impaired endothelial function in patients with ankylosing spondylitis: reply
- I. Sari and N. Akkoc
Rheumatology 2006; 45: 1319-a--a1320.
[Extract]
[Full Text]
- MATTERS ARISING
Impaired endothelial function in patients with ankylosing spondylitis
- H. Pieringer
Rheumatology 2006; 45: 1319.
[Extract]
[Full Text]
- GUIDELINES
BSR & BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults
- G. Coakley, C. Mathews, M. Field, A. Jones, G. Kingsley, D. Walker, M. Phillips, C. Bradish, A. McLachlan, R. Mohammed, and V. Weston on behalf of the British Society for Rheumatology Standards, Guidelines and Audit Working Group
Rheumatology 2006; 45: 1039-1041.
[Extract]
[Full Text]
[ Full Guidelines ]
- CLINICAL
Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-up
- L. Gossec, A. Le Henanff, M. Breban, E. Vignon, P. Claudepierre, V. Devauchelle, D. Wendling, E. Lespessailles, L. Euller-Ziegler, J. Sibilia, A. Perdriger, C. Alexandre, and M. Dougados
Rheumatology 2006; 45: 859-862.
[Abstract]
[Full Text]
- CLINICAL
In SAPHO syndrome anti-TNF- therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations
- A. Massara, P. L. Cavazzini, and F. Trotta
Rheumatology 2006; 45: 730-733.
[Abstract]
[Full Text]
- MATTERS ARISING
Positive and negative predictive values from published studies can be misleading for decision-making in clinical practice
- M. Rudwaleit and J. Sieper
Rheumatology 2006; 45: 779-b--b780.
[Extract]
[Full Text]
- MATTERS ARISING
Positive and negative predictive values from published studies can be misleading for decision-making in clinical practice: reply
- C. Duftner, C. Dejaco, and M. Schirmer
Rheumatology 2006; 45: 780-781.
[Extract]
[Full Text]
|
|
